<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03060954</url>
  </required_header>
  <id_info>
    <org_study_id>PSM29</org_study_id>
    <nct_id>NCT03060954</nct_id>
  </id_info>
  <brief_title>Non-Inferiority Study Comparing MINI WELL READY® and FineVision® in Patients With Cataract Surgery</brief_title>
  <official_title>A Multicentre, Controlled, Randomised, Single-blind, Two-armed Trial Evaluating the Visual Performance, Quality of Vision and Subjective Outcomes After Bilateral Implantation of MINI WELL Ready® or FineVision® in Patients With Cataract Surgery.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>SIFI SpA</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Opera CRO, a TIGERMED Group Company</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>SIFI SpA</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Interventional, Multicentre, controlled, randomized, single blind, twoarmed non-inferiority&#xD;
      trial&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To evaluate the non-inferiority of the progressive extended depth of focus Intraocular Lens&#xD;
      MINI WELL READY® in terms of visual performance, quality of vision and subjective outcomes&#xD;
      versus the trifocal Intraocular Lens FineVision® after a follow up period of 2-6 months.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    The clinical study is closed to further enrolment based on the lack of perceived need to&#xD;
    compare the study device with the control device.&#xD;
  </why_stopped>
  <start_date type="Actual">February 10, 2019</start_date>
  <completion_date type="Actual">March 5, 2020</completion_date>
  <primary_completion_date type="Actual">March 5, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Defocus curve - binocular</measure>
    <time_frame>6 months</time_frame>
    <description>Defocus curve assessment</description>
  </primary_outcome>
  <other_outcome>
    <measure>Refraction</measure>
    <time_frame>6 months</time_frame>
    <description>Ocular refraction evaluation</description>
  </other_outcome>
  <other_outcome>
    <measure>Visual Acuity Evaluation</measure>
    <time_frame>6 months</time_frame>
    <description>Uncorrected Distance Visual Acuity (UDVA)</description>
  </other_outcome>
  <other_outcome>
    <measure>Visual Acuity Evaluation</measure>
    <time_frame>6 months</time_frame>
    <description>Corrected Distance Visual Acuity (CDVA) Uncorrected Intermediate Visual Acuity (UIVA)</description>
  </other_outcome>
  <other_outcome>
    <measure>Visual Acuity Evaluation</measure>
    <time_frame>6 months</time_frame>
    <description>Distance Corrected Intermediate Visual Acuity (DCIVA)</description>
  </other_outcome>
  <other_outcome>
    <measure>Visual Acuity Evaluation</measure>
    <time_frame>6 months</time_frame>
    <description>Uncorrected Near Visual Acuity (UNVA)</description>
  </other_outcome>
  <other_outcome>
    <measure>Visual Acuity Evaluation</measure>
    <time_frame>6 months</time_frame>
    <description>Distance Corrected Near Visual Acuity (DCNVA)</description>
  </other_outcome>
  <other_outcome>
    <measure>Reading speed</measure>
    <time_frame>6 months</time_frame>
    <description>Reading speed performance</description>
  </other_outcome>
  <other_outcome>
    <measure>Halometry</measure>
    <time_frame>6 months</time_frame>
    <description>Halos evaluation</description>
  </other_outcome>
  <other_outcome>
    <measure>Contrast sensitivity</measure>
    <time_frame>6 months</time_frame>
    <description>Contrast sensitivity evaluation</description>
  </other_outcome>
  <other_outcome>
    <measure>Subject satisfaction questionnaire - VF-11R</measure>
    <time_frame>6 months</time_frame>
    <description>Subject satisfaction questionnaire - VF-11R &quot;revised version&quot;:&#xD;
Annex A: Subject's glasses independence and light dependence Annex B: Quality of Vision (QoV) questionnaire</description>
  </other_outcome>
  <other_outcome>
    <measure>Operative Complications / Postoperative Complications / Adverse Event Assessment</measure>
    <time_frame>6 months</time_frame>
    <description>Assessment of Operative Complications, Postoperative Complications, Adverse Events</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">8</enrollment>
  <condition>Cataract</condition>
  <condition>Presbyopia</condition>
  <arm_group>
    <arm_group_label>MINI WELL READY ®</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>BILATERAL IMPLANTATION OF MINI WELL READY®, A PROGRESSIVE EXTENDED DEPTH OF FOCUS INTRAOCULAR LENS IN PATIENTS WITH CATARACT SURGERY</description>
  </arm_group>
  <arm_group>
    <arm_group_label>FineVision ®</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>FINE VISION®, A TRIFOCAL INTRAOCULAR LENS IMPLANTATION IN PATIENTS WITH CATARACT SURGERY</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MINI WELL READY ®</intervention_name>
    <description>BILATERAL IMPLANTATION OF MINI WELL READY®, A PROGRESSIVE EXTENDED DEPTH OF FOCUS INTRAOCULAR LENS IN PATIENTS WITH CATARACT SURGERY</description>
    <arm_group_label>MINI WELL READY ®</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>FINE VISION®</intervention_name>
    <description>FINE VISION®, A TRIFOCAL INTRAOCULAR LENS IMPLANTATION IN PATIENTS WITH CATARACT SURGERY</description>
    <arm_group_label>FineVision ®</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age ≥ 18 years&#xD;
&#xD;
          -  Bilateral cataract surgery required, no other ocular comorbidities&#xD;
&#xD;
          -  Healthy corneas, not treated surgically&#xD;
&#xD;
          -  Available for second-eye surgery within 1 week of the initial operation&#xD;
&#xD;
          -  Spherical refraction between -8.00D and +6.00D&#xD;
&#xD;
          -  Willing to adhere to the study visit schedule&#xD;
&#xD;
          -  Normal anterior and posterior segments&#xD;
&#xD;
          -  Clear intraocular media - other than cataract&#xD;
&#xD;
          -  To benefit from a social security system before being enrolled&#xD;
&#xD;
          -  Written informed consent consistent with local regulation research in human subjects&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Any previous history of ocular trauma or prior ocular surgery (including previous&#xD;
             cataract surgery and CLRIs)&#xD;
&#xD;
          -  Ocular comorbidities determining potential postoperative Visual Acuity less than 0.50&#xD;
             decimal (0.3 logMAR)&#xD;
&#xD;
          -  Expected to require retinal laser treatment&#xD;
&#xD;
          -  A history of retinal detachment or predisposition for such disorder&#xD;
&#xD;
          -  Psudoexfoliation&#xD;
&#xD;
          -  Abnormal pupil size and position&#xD;
&#xD;
          -  Pupil size &gt; 7 mm under mesopic condition&#xD;
&#xD;
          -  Use of contact lenses 30 days before the preoperative visit&#xD;
&#xD;
          -  Corneal warpage (e.g. Keratoconus, Pellucid Marginal Corneal Degeneration or&#xD;
             Keratoglobus)&#xD;
&#xD;
          -  Corneal astigmatism greater than 0.75D&#xD;
&#xD;
          -  Zonular laxicity&#xD;
&#xD;
          -  Absence of adequate capsular support for the implant of the intraocular lens in the&#xD;
             capsular bag&#xD;
&#xD;
          -  Microphthalmus&#xD;
&#xD;
          -  Active ocular disease in the operative eye, for example, chronic uveitis,&#xD;
             proliferative diabetic retinopathy, chronic glaucoma unresponsive to medication,&#xD;
             corneal decompensation and corneal endothelial cell insufficiency (such as Fuch's&#xD;
             endothelial dystrophy)&#xD;
&#xD;
          -  Suspected microbial infection&#xD;
&#xD;
          -  Irregularities and capsulorexis decentralization&#xD;
&#xD;
          -  Surgical difficulties that may increase the risk of complications such as persistent&#xD;
             bleeding, significant iris damage, an uncontrollable intraocular hypertonia, or damage&#xD;
             due to significant vitreous loss&#xD;
&#xD;
          -  Patients in whom the intraocular lens may interfere with the ability to observe,&#xD;
             diagnose or treat diseases of the posterior segment&#xD;
&#xD;
          -  Patients in whom neither the posterior capsule nor the zonula can provide adequate&#xD;
             support to the lens&#xD;
&#xD;
          -  Subjects with any systemic disease that could increase operative risk or confound the&#xD;
             outcome&#xD;
&#xD;
          -  Pregnant or lactating or planning a pregnancy at the time of enrolment&#xD;
&#xD;
          -  Vulnerable subjects (children &lt;18 years, people in guardianship or trusteeship or&#xD;
             inability to give an informed consent)&#xD;
&#xD;
          -  Subjects participating in a concurrent clinical trial or if they have participated in&#xD;
             an ophthalmology clinical trial within the last 30 days&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gianluca Stivale</last_name>
    <role>Study Director</role>
    <affiliation>SIFI SpA</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ophtalmologie Hôpital Morvan</name>
      <address>
        <city>Brest</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Juge</name>
      <address>
        <city>Marseille</city>
        <zip>13008</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <removed_countries>
    <country>Romania</country>
  </removed_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>February 18, 2017</study_first_submitted>
  <study_first_submitted_qc>February 18, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">February 23, 2017</study_first_posted>
  <last_update_submitted>September 1, 2020</last_update_submitted>
  <last_update_submitted_qc>September 1, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 3, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
    <mesh_term>Presbyopia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

